148 related articles for article (PubMed ID: 37678990)
21. Reduced α-2,6 sialylation regulates cell migration in endometriosis.
Maignien C; Santulli P; Chouzenoux S; Gonzalez-Foruria I; Marcellin L; Doridot L; Jeljeli M; Grange P; Reis FM; Chapron C; Batteux F
Hum Reprod; 2019 Mar; 34(3):479-490. PubMed ID: 30753458
[TBL] [Abstract][Full Text] [Related]
22. Gating of the shaker potassium channel is modulated differentially by N-glycosylation and sialic acids.
Johnson D; Bennett ES
Pflugers Arch; 2008 May; 456(2):393-405. PubMed ID: 18043943
[TBL] [Abstract][Full Text] [Related]
23. Glycosylation in lymphoma: Biology and glycotherapy.
Suzuki O
Pathol Int; 2019 Aug; 69(8):441-449. PubMed ID: 31317621
[TBL] [Abstract][Full Text] [Related]
24. [Clinical and diagnostic significance of sialic acids determination in biological material].
Volkhina IV; Butolin EG
Biomed Khim; 2022 Jan; 68(1):7-17. PubMed ID: 35221292
[TBL] [Abstract][Full Text] [Related]
25. Sialic acids attached to N- and O-glycans within the Nav1.4 D1S5-S6 linker contribute to channel gating.
Ednie AR; Harper JM; Bennett ES
Biochim Biophys Acta; 2015 Feb; 1850(2):307-17. PubMed ID: 25450184
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the specificity of sialyltransferases toward mucin core 2, globo, and related structures. identification of the sialylation sequence and the effects of sulfate, fucose, methyl, and fluoro substituents of the carbohydrate chain in the biosynthesis of selectin and siglec ligands, and novel sialylation by cloned alpha2,3(O)sialyltransferase.
Chandrasekaran EV; Xue J; Xia J; Chawda R; Piskorz C; Locke RD; Neelamegham S; Matta KL
Biochemistry; 2005 Nov; 44(47):15619-35. PubMed ID: 16300412
[TBL] [Abstract][Full Text] [Related]
27. Glycoproteomic identification of potential glycoprotein biomarkers in ovarian cancer proximal fluids.
Kuzmanov U; Musrap N; Kosanam H; Smith CR; Batruch I; Dimitromanolakis A; Diamandis EP
Clin Chem Lab Med; 2013 Jul; 51(7):1467-76. PubMed ID: 23241603
[TBL] [Abstract][Full Text] [Related]
28. Glycosylation as a regulator of site-specific metastasis.
Bindeman WE; Fingleton B
Cancer Metastasis Rev; 2022 Mar; 41(1):107-129. PubMed ID: 34967926
[TBL] [Abstract][Full Text] [Related]
29. Cellular and Molecular Engineering of Glycan Sialylation in Heterologous Systems.
Hombu R; Neelamegham S; Park S
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641494
[TBL] [Abstract][Full Text] [Related]
30. Nutrient-deprived cancer cells preferentially use sialic acid to maintain cell surface glycosylation.
Badr HA; AlSadek DM; Mathew MP; Li CZ; Djansugurova LB; Yarema KJ; Ahmed H
Biomaterials; 2015 Nov; 70():23-36. PubMed ID: 26295436
[TBL] [Abstract][Full Text] [Related]
31. Rab11-mediated post-Golgi transport of the sialyltransferase ST3GAL4 suggests a new mechanism for regulating glycosylation.
Kitano M; Kizuka Y; Sobajima T; Nakano M; Nakajima K; Misaki R; Itoyama S; Harada Y; Harada A; Miyoshi E; Taniguchi N
J Biol Chem; 2021; 296():100354. PubMed ID: 33524390
[TBL] [Abstract][Full Text] [Related]
32. A new method for detection of tumor driver-dependent changes of protein sialylation in a colon cancer cell line reveals nectin-3 as TGFBR2 target.
Lee J; Warnken U; Schnölzer M; Gebert J; Kopitz J
Protein Sci; 2015 Oct; 24(10):1686-94. PubMed ID: 26177744
[TBL] [Abstract][Full Text] [Related]
33. Sialylation of CD55 by ST3GAL1 Facilitates Immune Evasion in Cancer.
Lin WD; Fan TC; Hung JT; Yeo HL; Wang SH; Kuo CW; Khoo KH; Pai LM; Yu J; Yu AL
Cancer Immunol Res; 2021 Jan; 9(1):113-122. PubMed ID: 33177111
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA and gynecologic cancers.
Kanekura K; Nishi H; Isaka K; Kuroda M
J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
[TBL] [Abstract][Full Text] [Related]
35. Cancer-Associated Fibroblasts in Conversation with Tumor Cells in Endometrial Cancers: A Partner in Crime.
Pradip D; Jennifer A; Nandini D
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502029
[TBL] [Abstract][Full Text] [Related]
36. Role of glycosylation in the anticancer activity of antibacterial peptides against breast cancer cells.
Han YY; Liu HY; Han DJ; Zong XC; Zhang SQ; Chen YQ
Biochem Pharmacol; 2013 Nov; 86(9):1254-62. PubMed ID: 23962446
[TBL] [Abstract][Full Text] [Related]
37. Sialic acid linkage-specific quantitative N-glycoproteomics using selective alkylamidation and multiplex TMT-labeling.
Yang H; Tian Z
Anal Chim Acta; 2022 Oct; 1230():340391. PubMed ID: 36192063
[TBL] [Abstract][Full Text] [Related]
38. Increasing the sialylation of therapeutic glycoproteins: the potential of the sialic acid biosynthetic pathway.
Bork K; Horstkorte R; Weidemann W
J Pharm Sci; 2009 Oct; 98(10):3499-508. PubMed ID: 19199295
[TBL] [Abstract][Full Text] [Related]
39. 5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer.
Saldova R; Dempsey E; Pérez-Garay M; Mariño K; Watson JA; Blanco-Fernández A; Struwe WB; Harvey DJ; Madden SF; Peracaula R; McCann A; Rudd PM
Epigenetics; 2011 Nov; 6(11):1362-72. PubMed ID: 22086115
[TBL] [Abstract][Full Text] [Related]
40. Epidemiologic analysis of breast and gynecologic cancers.
Hulka BS
Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
